These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

165 related items for PubMed ID: 15191020

  • 1. Asthma hospitalization risk and costs for patients treated with fluticasone propionate vs montelukast.
    Orsini L, Limpa-Amara S, Crown WH, Stanford RH, Kamal K.
    Ann Allergy Asthma Immunol; 2004 May; 92(5):523-9. PubMed ID: 15191020
    [Abstract] [Full Text] [Related]

  • 2. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast.
    Stempel DA, Mauskopf J, McLaughlin T, Yazdani C, Stanford RH.
    Respir Med; 2001 Mar; 95(3):227-34. PubMed ID: 11266241
    [Abstract] [Full Text] [Related]

  • 3. Asthma-related health care resource use among patients starting fluticasone or montelukast therapy.
    Allen-Ramey FC, Anstatt DT, Sajjan SG, Markson LE.
    Pharmacotherapy; 2005 Dec; 25(12):1752-60. PubMed ID: 16305295
    [Abstract] [Full Text] [Related]

  • 4. Observational study of the effects of using montelukast vs fluticasone in patients matched at baseline.
    Allen-Ramey FC, Duong PT, Riedel AA, Markson LE, Weiss KB.
    Ann Allergy Asthma Immunol; 2004 Oct; 93(4):373-80. PubMed ID: 15521374
    [Abstract] [Full Text] [Related]

  • 5. Patterns of asthma-related health care resource use in children treated with montelukast or fluticasone.
    Allen-Ramey FC, Markson LE, Riedel AA, Sajjan S, Weiss KB.
    Curr Med Res Opin; 2006 Aug; 22(8):1453-61. PubMed ID: 16870071
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Outcomes of patients treated with fluticasone propionate or montelukast sodium.
    Allen-Ramey FC, Duong PT, Goodman DC, Sajjan SG, Nelsen LM, Markson L.
    Manag Care Interface; 2003 Aug; 16(8):30-5. PubMed ID: 12964550
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy and cost of asthma care in children with asthma treated with fluticasone propionate and montelukast.
    Stempel DA, Kruzikas DT, Manjunath R.
    J Pediatr; 2007 Feb; 150(2):162-7. PubMed ID: 17236894
    [Abstract] [Full Text] [Related]

  • 13. A comparison of asthma-related expenditures for patients started on montelukast versus fluticasone propionate as monotherapy.
    Bukstein DA, Henk HJ, Luskin AT.
    Clin Ther; 2001 Sep; 23(9):1589-600. PubMed ID: 11589270
    [Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness comparison of salmeterol/fluticasone propionate versus montelukast in the treatment of adults with persistent asthma.
    Sheth K, Borker R, Emmett A, Rickard K, Dorinsky P.
    Pharmacoeconomics; 2002 Sep; 20(13):909-18. PubMed ID: 12381242
    [Abstract] [Full Text] [Related]

  • 15. Outcomes associated with initiation of different controller therapies in a Medicaid asthmatic population: a retrospective data analysis.
    Balkrishnan R, Nelsen LM, Kulkarni AS, Pleasants RA, Whitmire JT, Schechter MS.
    J Asthma; 2005 Feb; 42(1):35-40. PubMed ID: 15801326
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Adherence to asthma controller medication regimens.
    Stempel DA, Stoloff SW, Carranza Rosenzweig JR, Stanford RH, Ryskina KL, Legorreta AP.
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.